191 related articles for article (PubMed ID: 32731930)
1. Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction.
Kang DO; An H; Park GU; Yum Y; Park EJ; Park Y; Jang WY; Kim W; Choi JY; Roh SY; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Choi CU
J Am Coll Cardiol; 2020 Aug; 76(5):518-529. PubMed ID: 32731930
[TBL] [Abstract][Full Text] [Related]
2. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M
JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657
[TBL] [Abstract][Full Text] [Related]
3. NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction: a nationwide study.
Schjerning Olsen AM; Fosbøl EL; Pallisgaard J; Lindhardsen J; Lock Hansen M; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
Eur Heart J Cardiovasc Pharmacother; 2015 Apr; 1(2):107-14. PubMed ID: 27533979
[TBL] [Abstract][Full Text] [Related]
4. Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study.
Schjerning Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Lamberts M; Bjerring Olesen J; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
Circulation; 2011 May; 123(20):2226-35. PubMed ID: 21555710
[TBL] [Abstract][Full Text] [Related]
5. Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study.
Schjerning Olsen AM; Lindhardsen J; Gislason GH; McGettigan P; Hlatky MA; Fosbøl E; Køber L; Torp-Pedersen C; Lamberts M
BMJ; 2015 Oct; 351():h5096. PubMed ID: 26481405
[TBL] [Abstract][Full Text] [Related]
6. Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study.
Lamberts M; Lip GY; Hansen ML; Lindhardsen J; Olesen JB; Raunsø J; Olsen AM; Andersen PK; Gerds TA; Fosbøl EL; Torp-Pedersen C; Gislason GH
Ann Intern Med; 2014 Nov; 161(10):690-8. PubMed ID: 25402512
[TBL] [Abstract][Full Text] [Related]
7. Ongoing treatment with non-steroidal anti-inflammatory drugs at time of admission is associated with poorer prognosis in patients with first-time acute myocardial infarction.
Lamberts M; Fosbøl EL; Olsen AM; Hansen ML; Folke F; Kristensen SL; Olesen JB; Hansen PR; Køber L; Torp-Pedersen C; Gislason GH
Int J Cardiol; 2013 Sep; 168(2):832-7. PubMed ID: 23117013
[TBL] [Abstract][Full Text] [Related]
8. [Comment on "Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction. A Nationwide Cohort Study].
Mimoso J
Rev Port Cardiol; 2011 Jul; 30(7-8):689-90. PubMed ID: 22005315
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs and cardiovascular outcomes in women: results from the women's health initiative.
Bavry AA; Thomas F; Allison M; Johnson KC; Howard BV; Hlatky M; Manson JE; Limacher MC
Circ Cardiovasc Qual Outcomes; 2014 Jul; 7(4):603-10. PubMed ID: 25006185
[TBL] [Abstract][Full Text] [Related]
11. Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients--a nationwide study.
Olsen AM; Fosbøl EL; Lindhardsen J; Andersson C; Folke F; Nielsen MB; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
PLoS One; 2013; 8(1):e54309. PubMed ID: 23382889
[TBL] [Abstract][Full Text] [Related]
12. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
[TBL] [Abstract][Full Text] [Related]
13. Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort study.
Olsen AM; Fosbøl EL; Lindhardsen J; Folke F; Charlot M; Selmer C; Bjerring Olesen J; Lamberts M; Ruwald MH; Køber L; Hansen PR; Torp-Pedersen C; Gislason GH
Circulation; 2012 Oct; 126(16):1955-63. PubMed ID: 22965337
[TBL] [Abstract][Full Text] [Related]
14. Risk of Major Adverse Cardiovascular Events Associated with Concomitant Use of Antidepressants and Non-steroidal Anti-inflammatory Drugs: A Retrospective Cohort Study.
Jeong HE; Oh IS; Kim WJ; Shin JY
CNS Drugs; 2020 Oct; 34(10):1063-1074. PubMed ID: 32737794
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular Safety and Bleeding Risk Associated with Nonsteroidal Anti-Inflammatory Medications in Patients with Cardiovascular Disease.
Ross SJ; Elgendy IY; Bavry AA
Curr Cardiol Rep; 2017 Jan; 19(1):8. PubMed ID: 28138824
[TBL] [Abstract][Full Text] [Related]
16. Comparative cardiovascular safety of nonsteroidal anti-inflammatory drugs in patients with hypertension: a population-based cohort study.
Dong YH; Chang CH; Wu LC; Hwang JS; Toh S
Br J Clin Pharmacol; 2018 May; 84(5):1045-1056. PubMed ID: 29468706
[TBL] [Abstract][Full Text] [Related]
17. Studying additive interaction in a healthcare database: Case study of NSAIDs, cardiovascular profiles, and acute myocardial infarction.
Bally M; Nadeau L; Brophy JM
PLoS One; 2018; 13(8):e0201884. PubMed ID: 30096158
[TBL] [Abstract][Full Text] [Related]
18. Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation.
Kent AP; Brueckmann M; Fraessdorf M; Connolly SJ; Yusuf S; Eikelboom JW; Oldgren J; Reilly PA; Wallentin L; Ezekowitz MD
J Am Coll Cardiol; 2018 Jul; 72(3):255-267. PubMed ID: 30012318
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study.
Nam YH; Brensinger CM; Bilker WB; Leonard CE; Kasner SE; Grosser T; Li X; Hennessy S
PLoS One; 2018; 13(3):e0193800. PubMed ID: 29538453
[TBL] [Abstract][Full Text] [Related]
20. Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposure.
Bally M; Beauchamp ME; Abrahamowicz M; Nadeau L; Brophy JM
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):69-77. PubMed ID: 29171096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
